BENGALURU — Indian biopharmaceutical firm Biocon Ltd. expects the cost of developing new biosimilars to fall by

As the 2024 U.S. presidential election approaches, many top Wall Street executives are unsure about which candidate

Key Points CFPB Ends Bad Actor Registry The U.S. Consumer Financial Protection Bureau officially repealed a Biden-era

In August, the US job market showed weaker-than-anticipated growth, although the unemployment rate experienced a slight decrease.

Shelby Davis, a renowned investor, firmly believed in value investing, a strategy focused on buying stocks below

The growth rate of the U.S. services sector exhibited a deceleration in May, primarily due to a

President Trump is preparing to remove Federal Reserve Chair Jerome Powell, intensifying his long-standing clash with the